EQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma

Background: Over 20 susceptibility single-nucleotide polymorphisms (SNP) have been identified for esophageal adenocarcinoma (EAC) and its precursor, Barrett esophagus (BE), explaining a small portion of heritability.

Methods: Using genetic data from 4,323 BE and 4,116 EAC patients aggregated by international consortia including the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON), we conducted a comprehensive transcriptome-wide association study (TWAS) for BE/EAC, leveraging Genotype Tissue Expression (GTEx) gene-expression data from six tissue types of plausible relevance to EAC etiology: mucosa and muscularis from the esophagus, gastroesophageal (GE) junction, stomach, whole blood, and visceral adipose. Two analytical approaches were taken: standard TWAS using the predicted gene expression from local expression quantitative trait loci (eQTL), and set-based SKAT association using selected eQTLs that predict the gene expression.

Results: Although the standard approach did not identify significant signals, the eQTL set-based approach identified eight novel associations, three of which were validated in independent external data (eQTL SNP sets for EXOC3, ZNF641, and HSP90AA1).

Conclusions: This study identified novel genetic susceptibility loci for EAC and BE using an eQTL set-based genetic association approach.

Impact: This study expanded the pool of genetic susceptibility loci for EAC and BE, suggesting the potential of the eQTL set-based genetic association approach as an alternative method for TWAS analysis.

Citing Articles

Biologically targeted discovery-replication scan identifies G×G interaction in relation to risk of Barrett's esophagus and esophageal adenocarcinoma.

Yan L, He Q, Verma S, Zhang X, Giel A, Maj C HGG Adv. 2025; 6(2):100399.

PMID: 39755942 PMC: 11815673. DOI: 10.1016/j.xhgg.2025.100399.

Integrated mendelian randomization analyses highlight AFF3 as a novel eQTL-mediated susceptibility gene in renal cancer and its potential mechanisms.

Wang Q, Chen S, Wang G, Zhang T, Gao Y BMC Cancer. 2024; 24(1):739.

PMID: 38886730 PMC: 11181572. DOI: 10.1186/s12885-024-12513-1.

Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control Study.

Sunder-Plassmann R, Geusau A, Endler G, Weninger W, Wielscher M Cancers (Basel). 2023; 15(13).

PMID: 37444464 PMC: 10340609. DOI: 10.3390/cancers15133354.

References

Holmes R, Vaughan T . Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2006; 17(1):2-9. DOI: 10.1016/j.semradonc.2006.09.003. View

Olsen C, Pandeya N, Green A, Webb P, Whiteman D . Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am J Epidemiol. 2011; 174(5):582-90. DOI: 10.1093/aje/kwr117. View

Mancuso N, Gayther S, Gusev A, Zheng W, Penney K, Kote-Jarai Z . Large-scale transcriptome-wide association study identifies new prostate cancer risk regions. Nat Commun. 2018; 9(1):4079. PMC: 6172280. DOI: 10.1038/s41467-018-06302-1. View

Su Y, Di C, Bien S, Huang L, Dong X, Abecasis G . A Mixed-Effects Model for Powerful Association Tests in Integrative Functional Genomics. Am J Hum Genet. 2018; 102(5):904-919. PMC: 5986723. DOI: 10.1016/j.ajhg.2018.03.019. View

Levine D, Ek W, Zhang R, Liu X, Onstad L, Sather C . A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet. 2013; 45(12):1487-93. PMC: 3840115. DOI: 10.1038/ng.2796. View

Coleman H, Xie S, Lagergren J . The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology. 2017; 154(2):390-405. DOI: 10.1053/j.gastro.2017.07.046. View

Wang S, Katki H, Graubard B, Kahle L, Chaturvedi A, Matthews C . Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States. Am J Gastroenterol. 2021; 116(9):1844-1852. PMC: 8410651. DOI: 10.14309/ajg.0000000000001355. View

Bien S, Su Y, Conti D, Harrison T, Qu C, Guo X . Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer. Hum Genet. 2019; 138(4):307-326. PMC: 6483948. DOI: 10.1007/s00439-019-01989-8. View

Hoyo C, Cook M, Kamangar F, Freedman N, Whiteman D, Bernstein L . Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012; 41(6):1706-18. PMC: 3535758. DOI: 10.1093/ije/dys176. View

10.

Spechler S, Souza R . Barrett's esophagus. N Engl J Med. 2014; 371(9):836-45. DOI: 10.1056/NEJMra1314704. View

11.

Zhu Z, Zhang F, Hu H, Bakshi A, Robinson M, Powell J . Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016; 48(5):481-7. DOI: 10.1038/ng.3538. View

12.

Qi X, Li Y, Xiao J, Yuan W, Yan Y, Wang Y . Activation of transcriptional activities of AP-1 and SRE by a new zinc-finger protein ZNF641. Biochem Biophys Res Commun. 2005; 339(4):1155-64. DOI: 10.1016/j.bbrc.2005.11.124. View

13.

Steevens J, Botterweck A, Dirx M, van den Brandt P, Schouten L . Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol. 2009; 22(6):669-78. DOI: 10.1097/MEG.0b013e32832ca091. View

14.

Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx B . Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016; 48(3):245-52. PMC: 4767558. DOI: 10.1038/ng.3506. View

15.

Reid B, Li X, Galipeau P, Vaughan T . Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer. 2010; 10(2):87-101. PMC: 2879265. DOI: 10.1038/nrc2773. View

16.

Gavin A, Francisci S, Foschi R, Donnelly D, Lemmens V, Brenner H . Oesophageal cancer survival in Europe: a EUROCARE-4 study. Cancer Epidemiol. 2012; 36(6):505-12. DOI: 10.1016/j.canep.2012.07.009. View

17.

Friedman J, Hastie T, Tibshirani R . Regularization Paths for Generalized Linear Models via Coordinate Descent. J Stat Softw. 2010; 33(1):1-22. PMC: 2929880. View

18.

Barbeira A, Dickinson S, Bonazzola R, Zheng J, Wheeler H, Torres J . Exploring the phenotypic consequences of tissue specific gene expression variation inferred from GWAS summary statistics. Nat Commun. 2018; 9(1):1825. PMC: 5940825. DOI: 10.1038/s41467-018-03621-1. View

19.

Westra H, Peters M, Esko T, Yaghootkar H, Schurmann C, Kettunen J . Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet. 2013; 45(10):1238-1243. PMC: 3991562. DOI: 10.1038/ng.2756. View

20.

Engel L, Chow W, Vaughan T, Gammon M, Risch H, Stanford J . Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003; 95(18):1404-13. DOI: 10.1093/jnci/djg047. View